BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16818773)

  • 1. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
    Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
    J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
    Nair P; Melarkode R; Rajkumar D; Montero E
    Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of CD6 function through interaction with Galectin-1 and -3.
    Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
    FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lymphocyte receptor CD6 interacts with syntenin-1, a scaffolding protein containing PDZ domains.
    Gimferrer I; Ibáñez A; Farnós M; Sarrias MR; Fenutría R; Roselló S; Zimmermann P; David G; Vives J; Serra-Pagès C; Lozano F
    J Immunol; 2005 Aug; 175(3):1406-14. PubMed ID: 16034076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of CD6-mediated interactions in T cell activation and proliferation.
    Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
    J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
    Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
    J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.
    Zimmerman AW; Joosten B; Torensma R; Parnes JR; van Leeuwen FN; Figdor CG
    Blood; 2006 Apr; 107(8):3212-20. PubMed ID: 16352806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical Characterization of CD6-TCR/CD3 Interplay in T Cells.
    Meddens MBM; Mennens SFB; Celikkol FB; Te Riet J; Kanger JS; Joosten B; Witsenburg JJ; Brock R; Figdor CG; Cambi A
    Front Immunol; 2018; 9():2333. PubMed ID: 30356797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
    Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
    J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function.
    Chen D; Iijima H; Nagaishi T; Nakajima A; Russell S; Raychowdhury R; Morales V; Rudd CE; Utku N; Blumberg RS
    J Immunol; 2004 Mar; 172(6):3535-43. PubMed ID: 15004154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
    Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
    J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted effects of soluble human CD6 in experimental cancer models.
    Simões IT; Aranda F; Casadó-Llombart S; Velasco-de Andrés M; Català C; Álvarez P; Consuegra-Fernández M; Orta-Mascaró M; Merino R; Merino J; Alberola-Ila J; González-Aseguinolaza G; Carreras E; Martínez V; Lozano F
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.
    Oliveira MI; Gonçalves CM; Pinto M; Fabre S; Santos AM; Lee SF; Castro MA; Nunes RJ; Barbosa RR; Parnes JR; Yu C; Davis SJ; Moreira A; Bismuth G; Carmo AM
    Eur J Immunol; 2012 Jan; 42(1):195-205. PubMed ID: 21956609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
    Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
    Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adhesion molecules, their receptors, and their regulation: analysis of CD6-activated leukocyte cell adhesion molecule (ALCAM/CD166) interactions.
    Bowen MA; Aruffo A
    Transplant Proc; 1999; 31(1-2):795-6. PubMed ID: 10083342
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
    Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
    Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lck is required for activation-induced T cell death after TCR ligation with partial agonists.
    Yu XZ; Levin SD; Madrenas J; Anasetti C
    J Immunol; 2004 Feb; 172(3):1437-43. PubMed ID: 14734719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
    Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
    Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells.
    Osorio LM; Rottenberg M; Jondal M; Chow SC
    Immunology; 1998 Mar; 93(3):358-65. PubMed ID: 9640246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.
    Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
    Biochemistry; 1996 Sep; 35(38):12287-91. PubMed ID: 8823162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.